Brooke Manning
Overview
Explore the profile of Brooke Manning including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
16
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Aitken B, Downey L, Rose S, Manning B, Arkell T, Shiferaw B, et al.
Hum Psychopharmacol
. 2025 Feb;
40(2):e70002.
PMID: 39930713
Objective: To examine the effect of a low dose (10 mg) of methylphenidate on cognitive performance, visuospatial working memory (VSWM) and gaze behaviour capabilities in healthy adults. Methods: This randomised,...
2.
Manning B, Hayley A, Downey L
Eur Neuropsychopharmacol
. 2024 Sep;
88:50.
PMID: 39226859
No abstract available.
3.
Manning B, Hayley A, Catchlove S, Stough C, Downey L
Eur Neuropsychopharmacol
. 2024 Mar;
82:35-43.
PMID: 38490083
As cannabinoid-based medications gain popularity in the treatment of refractory medical conditions, it is crucial to examine the neurocognitive effects of commonly prescribed products to ensure associated safety profiles. The...
4.
Manning B, Arkell T, Hayley A, Downey L
J Psychopharmacol
. 2024 Feb;
38(3):247-257.
PMID: 38332655
Background: Despite increasing medical cannabis use, research has yet to establish whether and to what extent products containing delta-9-tetrahydrocannabinol (THC) impact driving performance among patients. Stable doses of prescribed cannabinoid...
5.
Manning B, Downey L, Narayan A, Hayley A
Addict Biol
. 2024 Jan;
29(1):e13359.
PMID: 38221807
Driving is a critical everyday task necessitating the rapid and seamless integration of dynamic visually derived information to guide neurobehaviour. Biological markers are frequently employed to detect Δ9-tetrahydrocannabinol (THC) consumption...
6.
Arkell T, Manning B, Downey L, Hayley A
CNS Drugs
. 2023 Nov;
37(11):981-992.
PMID: 37945917
Background And Objectives: Medical cannabis use is increasing in Australia and other jurisdictions, yet little is known about the effects of medical cannabis on cognitive function. Findings from studies of...
7.
Manning B, Hayley A, Catchlove S, Shiferaw B, Stough C, Downey L
J Psychopharmacol
. 2023 May;
37(5):472-483.
PMID: 37129083
Background: Medicinal cannabis products containing Δ9-tetrahydrocannabinol (THC) are increasingly accessible. Yet, policy guidelines regarding fitness to drive are lacking, and cannabinoid-specific indexations of impairment are underdeveloped. Aims: To determine the...
8.
Narayan A, Downey L, Manning B, Hayley A
Neurosci Biobehav Rev
. 2022 Nov;
143:104941.
PMID: 36370842
Cannabidiol's (CBD) safety profile and broad action has made it a popular treatment option for anxiety and co-occurring sleep disturbance. However, its efficacy in healthy and clinical populations, treatment duration,...